Previous 10 | Next 10 |
JACKSON CENTER, PA / ACCESSWIRE / August 31, 2020 / Halberd Corporation (OTC PINK: HALB ) today announced the signing of a development agreement with Arizona State University (ASU) to conduct sponsored research to develop Halberd's Covid-19 treatments. The work will focus on developing antib...
JACKSON CENTER, PA / ACCESSWIRE / August 27, 2020 / Halberd Corp. (OTC PINK: HALB ) is pleased to announce the successful completion of its search for a major research university partner. The University, to be announced, is engaged to develop compounds for use in Halberd's patented extracorp...
JACKSON CENTER, PA / ACCESSWIRE / August 18, 2020 / Halberd Corp. (OTC PINK: HALB ) Chairman, President & CEO of Halberd Corporation, William A. Hartman, has received a number of questions from shareholders regarding the extracorporeal process for treatment of Covid-19. Below, Mr. Hartma...
JACKSON CENTER, PA / ACCESSWIRE / August 12, 2020 / Halberd Corp. (OTC PINK: HALB ) today announced the addition of Edson Brito to the Scientific Advisory Board. Mr. Brito is CEO and Chief Business Development Officer of Cellybri Advanced Therapies in Brazil. Mr. Brito graduated with a Ch...
JACKSON CENTER, PA / ACCESSWIRE / August 10, 2020 / Halberd Corp. (OTC PINK: HALB ) today confirmed the addition of Dr. Abdon Nanhay as a member of the Scientific Advisory Board. Dr. Nanhay, a Brazilian physician, has over 25 years of experience in health and biological sciences Dr. Nan...
JACKSON CENTER, PA / ACCESSWIRE / August 6, 2020 / Halberd Corp. (OTC PINK: HALB ) today confirmed the signing of Dr. Gregory George as a member of the Scientific Advisory Board. Dr. George is a Family Medicine Specialist in Sharon, PA and is affiliated with the Sharon Regional Health Syst...
JACKSON CENTER, PA / ACCESSWIRE / August 4, 2020 / Halberd Corp. (OTC PINK: HALB ) announced today that they have secured non-dilutive, grant-based funding for their patent pending Covid-19 treatment(s). Newly formed Nonprofit Organization, Epidemiologic Solutions Corporation, a Louisiana, I...
Will Assist with Covid-19 Efforts and the Brain JACKSON CENTER, PA / ACCESSWIRE / July 27, 2020 / Halberd Corp. (OTC PINK: HALB ) announced the appointment of Carl Eller, retired NFL Pro Football Hall of Famer, and President of the NFL Retired Players Association as a consultant. Mr. El...
JACKSON CENTER, PA / ACCESSWIRE / July 22, 2020 / Halberd Corporation (OTC PINK: HALB ) announced their Chief Technical Officer and Head of Scientific Advisory Board, Dr. Patricio Reyes presented A Community Information Session virtual event hosted yesterday by the Brain Injury Alliance ...
JACKSON CENTER, PA / ACCESSWIRE / July 16, 2020 / Halberd Corp. (OTC PINK: HALB ) intends to use laser technology to eradicate the COVID-19 Coronavirus. This patent pending treatment introduces one or more fluorescent antibody-antigen complexing agents to bind with the target antigen(s) (i.e...
News, Short Squeeze, Breakout and More Instantly...
Walt Disney once said, "All our dreams can come true if we have the courage to pursue them". JACKSON CENTER, PA / ACCESSWIRE / May 22, 2024 / Halberd Corporation (OTC PINK:HALB) in cooperation with Athena GTX, Inc is standing at the threshold of some major advancements to treat the issues ...
Daniel J. Harvey and Adam Lambert Improving Servicemember Transition to Reduce Veteran Suicide Act, passed the U.S. House unanimously. JACKSON CENTER, PA / ACCESSWIRE / May 9, 2024 / Halberd Corporation's (OTC PINK:HALB) two active programs for the treatment and mitigation of the negative ...
LDN+ Drug Designed to Combat PTSD and Suicidal Ideation JACKSON CENTER, PA / ACCESSWIRE / April 30, 2024 / Halberd Corporation (OTC PINK:HALB) announced a pre-pilot study of its patented LDN+ drug with military volunteers has now begun with limited participants but is currently expected to...